• $1.7M
    Market Cap
  • -58.06%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 9
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.01
$0.02
$0.01
1-Year Range
$0.01
$0.06
$0.01
Latest Close$0.01
Change
$0.00 (0.00%)
Volume74,400
Market Cap$1.7M
Shares Outstanding131.4M
P/E (TTM)-1.33
Diluted EPS (TTM)-$0.010
Enterprise Value$1.7M

Information as of 06/02/2026

Company Profile

BURZYNSKI RESEARCH INSTITUTE INC
https://propcitweb.ddns.net:83
$1.7M
Market Cap
-$1.3M
Net Income
Sector: Healthcare
Industry: Biotechnology
9432 Katy Freeway, Houston, TX, United States, 77055
713 335 5697

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.

Key Executives

  • Patryk Goscianski
  • Tomasz Janicki
  • Stanislaw R. Burzynski

Current Ownership Distribution

  • Other131.4M (99.98%)
  • Institutions29,000 (0.02%)
  • Mutual Funds0 (0.00%)
  • Insiders0 (0.00%)